Glucocorticoid dysregulations and their clinical correlates. From receptors to therapeutics - Wikidata - wikimedia - TriplyDB

Glucocorticoid dysregulations and their clinical correlates. From receptors to therapeutics

Glucocorticoid dysregulations and their clinical correlates. From receptors to therapeutics

http://www.wikidata.org/entity/Q24618470

about

Stress-induced sex differences: adaptations mediated by the glucocorticoid receptor Beyond the monoaminergic hypothesis: neuroplasticity and epigenetic changes in a transgenic mouse model of depression Gastrodiae Rhizoma (tiān má): a review of biological activity and antidepressant mechanisms Glucocorticoid regulation of inflammation and its functional correlates: from HPA axis to glucocorticoid receptor dysfunction Bone density and depressive disorder: a meta-analysis Genetic Moderation of Stress Effects on Corticolimbic Circuitry Dissection of glucocorticoid receptor-mediated inhibition of the hypothalamic-pituitary-adrenal axis by gene targeting in mice.Chronic stress, glucocorticoid receptor resistance, inflammation, and disease risk.Stress and Alterations in Bones: An Interdisciplinary Perspective Association analysis of the glucocorticoid receptor gene (NR3C1) haplotypes (ER22/23EK, N363S, BclI) with mood and anxiety disorders in patients with asthma Increased inflammatory signaling and lethality of influenza H1N1 by nuclear thioredoxin-1.Biomarkers in development of psychotropic drugs.Postnatal epigenetic modification of glucocorticoid receptor gene in preterm infants: a prospective cohort study.Conference summary and conclusions. A comprehensive approach to predicting and managing mood effects of glucocorticoids Neuropsychological care and rehabilitation of cancer patients with chemobrain: strategies for evaluation and intervention development.Depressogenic vulnerability and gender-specific patterns of neuro-immune dysregulation: What the ratio of cortisol to C-reactive protein can tell us about loss of normal regulatory control.Stress-induced alterations in anxiety-like behavior and adaptations in plasticity in the bed nucleus of the stria terminalis.Pregnenolone sulfate as a modulator of synaptic plasticity.Effects of city living on the mesolimbic reward system-An fmri study.Gene-environment interactions: early life stress and risk for depressive and anxiety disorders.Cortisol and inflammatory processes in ovarian cancer patients following primary treatment: relationships with depression, fatigue, and disability.The influence of maternal prenatal and early childhood nutrition and maternal prenatal stress on offspring immune system development and neurodevelopmental disorders.Region-specific alterations in glucocorticoid receptor expression in the postmortem brain of teenage suicide victims.Association between glucocorticoid receptor methylation and hippocampal subfields in major depressive disorder.From stress to inflammation and major depressive disorder: a social signal transduction theory of depression.Recent advances in the development of novel glucocorticoid receptor modulators.Regulation of the glucocorticoid response to stress-related disorders by the Hsp90-binding immunophilin FKBP51.Using optogenetics to translate the "inflammatory dialogue" between heart and brain in the context of stress.Neuronal control of breathing: sex and stress hormones.Age-related hearing loss and dementia: a 10-year national population-based study.Identification of Relationships Between Interleukin 15 mRNA and Brain-Derived Neurotrophic Factor II mRNA Levels With Formal Components of Temperament in Asthmatic Patients.Optimal elevation of β-cell 11β-hydroxysteroid dehydrogenase type 1 is a compensatory mechanism that prevents high-fat diet-induced β-cell failure.Microglia: An Interface between the Loss of Neuroplasticity and Depression Biological outcome measurements for behavioral interventions in multiple sclerosis.Testing the biological embedding hypothesis: Is early life adversity associated with a later proinflammatory phenotype?Serum folate and B12 levels in association with cognitive impairment among seniors: results from the VELESTINO study in Greece and meta-analysis.Does stress-induced release of interleukin-1 cause liver injury?Differential regulation of glucocorticoid receptor expression in distinct columns of periaqueductal grey in rats with behavioural disability following nerve injury.Depression, evening salivary cortisol and inflammation in chronic fatigue syndrome: A psychoneuroendocrinological structural regression model.When inflammation and depression go together: The longitudinal effects of parent-child relationships.

P2860

Q24596885-3489CA5E-1010-4B0E-84D7-D128A3ADB8F5 Q24629465-047290C2-E4BC-47B9-B46B-B08D69E27C4C Q27006845-82ECCC51-FC45-4C0A-97E2-51B38DDDF61B Q27024383-040F5CD3-804B-477C-B05C-701997CA8725 Q28386277-9C09B06D-D626-478D-B914-5744E18B2BC0 Q28606435-CA35C098-5C25-4498-8D3E-AE864B40325C Q30394714-BC8629AC-53A7-48CC-A31D-66434B04DA19 Q30427006-08201F5A-04EF-4E9D-93CE-E72F54048B76 Q33619640-52D45EAC-344A-4012-8C67-0E2F4D5983C7 Q33837383-9BA69BA0-81DE-468B-B4C2-FF94AE99C7B9 Q33883771-1DC6D2BB-C5D0-4D90-B719-2100CF9784D5 Q33993209-4F83E1E4-D9A1-41F9-8B53-944E61FF74A5 Q33995985-BB224211-5B98-4753-A9C9-8DCE6D545047 Q34103094-2B387990-FBB1-4FEF-AE77-C41B9BDD073D Q34633028-AD593F38-984D-4B6E-837E-8CF0154FE579 Q34765212-A4B3FA51-EBAA-4CC9-8FCF-D58861AE34C1 Q35056648-EDED84F4-2367-411E-99DF-3F1535DE5F87 Q36224315-77E7DDD3-9E64-48FD-AD3F-F734C2DBF285 Q36342879-77E776B2-B19E-4CF5-914C-653906DAFBF6 Q36737873-B76385E9-281F-4FDE-8963-459C2C6836F8 Q36971577-FAC80B05-FDFA-417B-8160-9E7EB31983D8 Q37057724-FF8DF99D-1D01-42D1-9C21-7840AF4CA150 Q37265833-49723BB6-1E5D-4B01-A4DF-4EF4E299CEC9 Q37499484-F896C91B-6EA0-4AEC-A82E-FE14C8DC3433 Q37735473-4176B7FD-FE00-4435-A6A7-20F7E4046136 Q37765564-82B37900-2F28-4842-8CC6-4A010A4C6890 Q38006721-60B4A408-C61C-4EFA-AF30-F2C2C24FB981 Q38029531-F31C62A5-B11A-4478-8897-69EC7C24CC7F Q38111735-89F36D76-DE3D-4101-8760-03C1A855AE0E Q38947089-BE8355CD-18B6-499A-9ABD-09FD07F990D1 Q39998957-D3FB60D9-C940-4231-B2DC-C1FD356E965F Q41314761-3A9F926C-4B0B-40D2-A971-1635AB440473 Q41699494-122BD1E0-C710-4A9A-8701-B476AB872896 Q42789516-4E4D6C13-2DD9-4399-9E74-703B434ECE87 Q42995233-53D66957-AD60-4338-8A85-E6EE8FD8AFB6 Q44678255-7532BB24-07DC-44FE-9EDD-6B2D47E60A75 Q46523965-F3903DA4-033C-432E-8941-3A084B487511 Q46614237-74D30337-D1FE-41B5-8A69-11DACC753705 Q47636926-28F350BE-FF3C-49BF-9377-4B53CE0FE4F2 Q47701111-B98D17C0-C1A3-40A4-B243-314321DFBB30

P2860

Glucocorticoid dysregulations and their clinical correlates. From receptors to therapeutics

http://www.wikidata.org/entity/Q24618470

description

2009 nî lūn-bûn

@nan

2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Glucocorticoid dysregulations ...... From receptors to therapeutics

@ast

Glucocorticoid dysregulations ...... From receptors to therapeutics

@en

Glucocorticoid dysregulations ...... From receptors to therapeutics

@nl

type

label

Glucocorticoid dysregulations ...... From receptors to therapeutics

@ast

Glucocorticoid dysregulations ...... From receptors to therapeutics

@en

Glucocorticoid dysregulations ...... From receptors to therapeutics

@nl

prefLabel

Glucocorticoid dysregulations ...... From receptors to therapeutics

@ast

Glucocorticoid dysregulations ...... From receptors to therapeutics

@en

Glucocorticoid dysregulations ...... From receptors to therapeutics

@nl

P1433

Q24618470-EC30F59C-B191-47B4-ACB0-95A14C10FA3F

P1476

Q24618470-A3444461-CF49-44B6-93F0-44A9DC802F12

P2093

Q24618470-0F888E94-B615-4157-8ED7-B212434ACA30

Q24618470-A89B9D44-DA72-4836-81C4-DF9C8C18324F

Q24618470-AA76E9B7-B71D-4573-91D7-BC45A6AE6C3B

P2860

Q24618470-01B704B4-8126-4AB1-B1B3-7F95AE11D267

Q24618470-02BD38C6-F0A7-431A-807F-D690BEED3A08

Q24618470-04722EE0-D4F6-463E-A72F-11C829A11C57

Q24618470-051C651A-A71A-433C-910C-76EEFAAA513B

Q24618470-0A1175CA-DDA3-4484-BBE6-A195C0962CF4

Q24618470-0B612C3B-766B-4671-A5C2-9BBDB6D385C3

Q24618470-0CB0DB96-FC0C-4135-B9D7-0719601BF4E7

Q24618470-11B03BD6-0D62-4F3A-8B7B-F07DC275F438

Q24618470-1217E4C0-6347-44FB-B0A0-C22E6203E5C9

Q24618470-16081D46-FACF-4E8E-AAED-0D071D839974

P304

Q24618470-5AA174B1-26A3-4C2F-928C-3647641B0FE9

P31

Q24618470-AF3519B3-5915-4E1C-AD3A-EA701E152DBA

P3181

Q24618470-525A09A0-89DB-40F2-B589-188650F908F6

P356

Q24618470-40B5F5F7-A306-47AD-B9B6-9F8A94D03E3A

P407

Q24618470-C7B42246-1AD1-4F7F-836D-0A57B7461961

P433

Q24618470-D314193D-7D8C-4C98-ACB3-6E75CD99C113

P478

Q24618470-D218D5A6-C04D-4F82-B269-831A12F96B8F

P577

Q24618470-5C2C5B15-DF79-4A2F-BCE0-11BF3C42E1A5

P5875

Q24618470-F6791983-7BB1-448E-8A3A-7F6C0E1E5C03

P698

Q24618470-EE250FD4-ED52-44F9-8440-7B01A4FB246A

P921

Q24618470-FE523592-7398-43F9-BE3E-F76F89EAA07E

P932

Q24618470-0DCC7DD1-D5BB-4735-BDA2-F876B5FAEA8B

P3181

P356

J.1749-6632.2009.04987.X

P1433

Annals of the New York Academy of Sciences

P1476

Glucocorticoid dysregulations ...... From receptors to therapeutics

@en

P2093

Andrea H Marques

http://www.w3.org/2001/XMLSchema#string

Esther M Sternberg

http://www.w3.org/2001/XMLSchema#string

Marni N Silverman

http://www.w3.org/2001/XMLSchema#string

P2860

Immune modulation of the hypothalamic-pituitary-adrenal (HPA) axis during viral infection

Cytokines sing the blues: inflammation and the pathogenesis of depression

From inflammation to sickness and depression: when the immune system subjugates the brain

Depression during pegylated interferon-alpha plus ribavirin therapy: prevalence and prediction

Molecular mechanisms of corticosteroid actions

Neuroendocrine regulation of immunity

Minireview: 11beta-hydroxysteroid dehydrogenase type 1- a tissue-specific amplifier of glucocorticoid action

Physiology and neurobiology of stress and adaptation: central role of the brain

Antiinflammatory action of glucocorticoids--new mechanisms for old drugs

Estrogen receptor (ER)beta isoforms rather than ERalpha regulate corticotropin-releasing hormone promoter activity through an alternate pathway

P304

1-18

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1533776

http://www.w3.org/2001/XMLSchema#string

P356

10.1111/J.1749-6632.2009.04987.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

1179

http://www.w3.org/2001/XMLSchema#string

P577

2009-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

38082758

http://www.w3.org/2001/XMLSchema#string

P698

19906229

http://www.w3.org/2001/XMLSchema#string

P921

P932

2933142

http://www.w3.org/2001/XMLSchema#string